Sumanta Pal
MD
Co-Director, Kidney Cancer Program
👥Biography 个人简介
Sumanta Pal has led research on non-clear cell RCC subtypes and advanced sequencing strategies for metastatic RCC. He contributed to the CABOSUN trial comparing cabozantinib versus sunitinib in the first-line setting. His work on papillary and chromophobe RCC has provided some of the limited prospective evidence for non-clear cell histologies. He is active in global RCC consortia and cooperative group trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Sumanta Pal 的研究动态
Follow Sumanta Pal's research updates
留下邮箱，当我们发布与 Sumanta Pal（City of Hope National Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment